SIGA (SIGA)
Supplies oral and IV TPOXX for smallpox preparedness programs.
$3.17
After hours0.00 (0.00%)
At close$3.17(−2.76%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 9 | 116 | 25 | 22 | 10 | 81 | 7 | 81 | 3 | 4 | 6 | 41 |
| Cost of revenue | 5 | 17 | 6 | 12 | 2 | 14 | 0 | 26 | 1 | 3 | 3 | 18 |
| Gross profit | 5 | 99 | 19 | 9 | 8 | 67 | 7 | 56 | 2 | 1 | 3 | 23 |
| 6 | 7 | 8 | 8 | 8 | 10 | 9 | 10 | 12 | 10 | 9 | 10 | |
| Research & development | 0 | 0 | 0 | 3 | 1 | 3 | 3 | 4 | 7 | −8 | 2,704,704 | 8 |
| 6 | 7 | 8 | 6 | 5 | 7 | 6 | 5 | 5 | −13 | 4,673,014 | 5 | |
| General & administrative | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 |
| Other expenses | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 32 | −7,377,709 | −3 |
| Operating income | −1 | 92 | 11 | 1 | 1 | 57 | −2 | 46 | −10 | −10 | −5 | 14 |
| 1 | 1 | 2 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 1 | 1 | |
| Interest income | 0 | 1 | 0 | 0 | 0 | 0 | 2 | 2 | 0 | 2 | 1 | 0 |
| Interest expense | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income | 0 | −2 | −2 | −1 | −1 | −1 | −2 | −2 | −2 | −2 | −1 | −1 |
| Income before tax | 0 | 93 | 13 | 2 | 2 | 59 | −1 | 47 | −8 | −8 | −4 | 15 |
| Income tax expense | 0 | 21 | 3 | 1 | 1 | 13 | 0 | 12 | −2 | −3 | −1 | 2 |
| Net income from continuing operations | 0 | 72 | 10 | 2 | 1 | 46 | 0 | 35 | −6 | −5 | −3 | 12 |
| Net income | 0 | 72 | 10 | 2 | 1 | 46 | 0 | 35 | −6 | −5 | −3 | 12 |
| EPS, basic | −$0.01 | $1.02 | $0.14 | $0.03 | $0.02 | $0.64 | −$0.01 | $0.50 | −$0.09 | −$0.08 | −$0.05 | $0.17 |
| EPS, diluted | −$0.01 | $1.02 | $0.14 | $0.03 | $0.02 | $0.64 | −$0.01 | $0.49 | −$0.09 | −$0.08 | −$0.05 | $0.17 |
| Weighted average shares, basic | 71 | 71 | 71 | 71 | 71 | 71 | 71 | 71 | 72 | 72 | 72 | 72 |
| Weighted average shares, diluted | 71 | 71 | 72 | 72 | 72 | 72 | 71 | 72 | 72 | 72 | 72 | 72 |
| EBITDA | −1 | 94 | 13 | 3 | 2 | 59 | 0 | 47 | −8 | −8 | −4 | 15 |
| Depreciation & amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | −1 | 94 | 13 | 2 | 2 | 59 | −1 | 47 | −8 | −8 | −4 | 15 |